Next, to investigate whether MDK-driven immune-suppression dampens the effect of immune checkpoint blockade (ICB) therapy, we developed a humanized mouse model engrafted with pre-nodal cells from the tumor culture of patient HN279 and treated the mice with PD1-blockade. This evidence concerns the gene MDK and neoplasm.